-
Product Insights
Varicose Veins Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Varicose Veins Global Clinical Trials Review, H2, 2018" provides an overview of Varicose Veins clinical trials scenario. This report provides top line data relating to the clinical trials on Varicose Veins. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Venous Leg Ulcers (Crural Ulcer) Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Venous Leg Ulcers (Crural Ulcer) Global Clinical Trials Review, H2, 2018" provides an overview of Venous Leg Ulcers (Crural Ulcer) clinical trials scenario. This report provides top line data relating to the clinical trials on Venous Leg Ulcers (Crural Ulcer). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Analyst Opinions
HNWI Asset Allocation 2020
This report looks at a detailed breakdown from WealthInsight’s proprietary country report model of HNWI populations and wealth. It provides an analysis of HNWI demographics based on a unique analysis of the HNWI dossier database. It analyses trends in HNWI investments by asset class, and looks at a breakdown of foreign and alternative investments. It provides an in-depth analysis of competitor product strategy, innovation, and mergers and acquisitions, and identifies current and future opportunities available to providers in selected core...
-
Analyst Opinions
Insight Report: Business Strategies for Targeting HNWIs and UHNWIs in Latin America
This report provides insights into Latin American wealth management market. It firstly looks at the market size of HNWIs and UHNWIs in Latin America, alongside demographic trends, drivers of and barriers to the HNWI and UHNWI markets. It also identifies key regulatory issues facing wealth advisors. The report’s main chapter examines financial product and service offerings in Latin America, highlights the role of family offices, and outlines business strategies for targeting HNWIs and UHNWIs, such as expansion, client and marketing...
-
Sector Analysis
Boilers, Turbines and Generators (BTG) for Thermal Power – Market Size, Competitive Landscape, Key Country Analysis and Forecasts to 2020
GlobalData’s latest report “Boilers, Turbines and Generators (BTG) for Thermal Power - Market Size, Competitive Landscape, Key Country Analysis and Forecasts to 2020” provides comprehensive information and understanding of the BTG market. The report offers in-depth analysis of BTG market at global, regional (Asia-Pacific, Americas, Europe, and Middle East and Africa) and key countries (US, China, India, Republic of Korea, Germany, UK, Saudi Arabia, South Africa, Egypt, Turkey, Poland, and Nigeria) level. The report analyzes the global and regional BTG...
-
Sector Analysis
Wealth in Brazil: HNW Investors; Understanding HNW investors and wealth management strategies.
The majority of wealth in Brazil originates from the construction and finance industries, and can be attributed to a range of sources. These investors are confident enough to deal with their financial affairs, but to gain access to sophisticated products and achieve better returns they opt for management services. Investment portfolios are built around cash and bonds, but it is expected that alternative holdings will continue to gain importance.
-
Product Insights
Varicose Veins Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Varicose Veins Global Clinical Trials Review, H2, 2016" provides an overview of Varicose Veins clinical trials scenario. This report provides top line data relating to the clinical trials on Varicose Veins. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
PharmaPoint: Colorectal Cancer – Global Drug Forecast and Market Analysis to 2025
The colorectal cancer (CRC) market, considering the sales of both branded treatments and generic chemotherapy, is expected to experience a moderate growth between 2015 and 2025. The main drivers of growth will be the expected increased number of diagnosed CRC incidence, and the launch and uptake of premium-priced therapies. Traditionally, the CRC market has been dominated by two therapeutic classes: angiogenesis and EGFR inhibitors. However, the efficacy of these agents is limited by the insurgence of acquired resistance. Further, RAS...
-
Sector Analysis
Insight Report: Business Strategies for Targeting HNWIs and UHNWIs in Latin America
This report provides insights into Latin American wealth management market. It firstly looks at the market size of HNWIs and UHNWIs in Latin America, alongside demographic trends, drivers of and barriers to the HNWI and UHNWI markets. It also identifies key regulatory issues facing wealth advisors. The report’s main chapter examines financial product and service offerings in Latin America, highlights the role of family offices, and outlines business strategies for targeting HNWIs and UHNWIs, such as expansion, client and marketing...
-
Product Insights
Drug Overdose Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Drug Overdose Global Clinical Trials Review, H2, 2017" provides an overview of Drug Overdose clinical trials scenario. This report provides top line data relating to the clinical trials on Drug Overdose. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...